New promises and challenges in the treatment of advanced non-small-cell lung cancer.
Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, Jänne PA, Peters S, Hirsch FR.
Lancet. 2024 Aug 24;404(10454):803-822. doi: 10.1016/S0140-6736(24)01029-8. Epub 2024 Aug 6.
Update 2020: Management of Non-Small Cell Lung Cancer.
Alexander M, Kim SY, Cheng H.
Lung. 2020 Dec;198(6):897-907. doi: 10.1007/s00408-020-00407-5. Epub 2020 Nov 11.
Lung Cancer: Targeted Therapy in 2025.
Bouchard N, Daaboul N.
Curr Oncol. 2025 Mar 2;32(3):146. doi: 10.3390/curroncol32030146.
Lung cancer: current therapies and new targeted treatments.
Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, Paz-Ares L.
Lancet. 2017 Jan 21;389(10066):299-311. doi: 10.1016/S0140-6736(16)30958-8. Epub 2016 Aug 27.
Emerging Targets in Non-Small Cell Lung Cancer.
Liu L, Soler J, Reckamp KL, Sankar K.
Int J Mol Sci. 2024 Sep 18;25(18):10046. doi: 10.3390/ijms251810046.
Advancements in small cell lung cancer.
Lee JH, Saxena A, Giaccone G.
Semin Cancer Biol. 2023 Aug;93:123-128. doi: 10.1016/j.semcancer.2023.05.008. Epub 2023 May 24.
Lung cancer: Biology and treatment options.
Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P.
Biochim Biophys Acta. 2015 Dec;1856(2):189-210. doi: 10.1016/j.bbcan.2015.08.002. Epub 2015 Aug 19.
Immunotherapy for resectable lung cancer.
Dennehy C, Conroy MR, Forde PM.
Cancer. 2025 May 15;131(10):e35849. doi: 10.1002/cncr.35849.
Abandoning the Notion of Non-Small Cell Lung Cancer.
Relli V, Trerotola M, Guerra E, Alberti S.
Trends Mol Med. 2019 Jul;25(7):585-594. doi: 10.1016/j.molmed.2019.04.012. Epub 2019 May 30.
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options.
Zugazagoitia J, Paz-Ares L.
J Clin Oncol. 2022 Feb 20;40(6):671-680. doi: 10.1200/JCO.21.01881. Epub 2022 Jan 5.
